IL103978A - שילובים רוקחיים של רניטידין ביסמות ציטרט ותרכובת אנטי דלקתית שאינה סטרואיד לטיפול במצבים דלקתיים או להשכחת כאבים - Google Patents

שילובים רוקחיים של רניטידין ביסמות ציטרט ותרכובת אנטי דלקתית שאינה סטרואיד לטיפול במצבים דלקתיים או להשכחת כאבים

Info

Publication number
IL103978A
IL103978A IL103978A IL10397892A IL103978A IL 103978 A IL103978 A IL 103978A IL 103978 A IL103978 A IL 103978A IL 10397892 A IL10397892 A IL 10397892A IL 103978 A IL103978 A IL 103978A
Authority
IL
Israel
Prior art keywords
bismuth citrate
analgesia
steroidal anti
treating
ranitidine bismuth
Prior art date
Application number
IL103978A
Other languages
English (en)
Other versions
IL103978A0 (en
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919126027A external-priority patent/GB9126027D0/en
Priority claimed from GB929206083A external-priority patent/GB9206083D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL103978A0 publication Critical patent/IL103978A0/xx
Publication of IL103978A publication Critical patent/IL103978A/he

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL103978A 1991-12-06 1992-12-04 שילובים רוקחיים של רניטידין ביסמות ציטרט ותרכובת אנטי דלקתית שאינה סטרואיד לטיפול במצבים דלקתיים או להשכחת כאבים IL103978A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919126027A GB9126027D0 (en) 1991-12-06 1991-12-06 Medicaments
GB929206083A GB9206083D0 (en) 1992-03-20 1992-03-20 Medicaments

Publications (2)

Publication Number Publication Date
IL103978A0 IL103978A0 (en) 1993-05-13
IL103978A true IL103978A (he) 1998-06-15

Family

ID=26299971

Family Applications (1)

Application Number Title Priority Date Filing Date
IL103978A IL103978A (he) 1991-12-06 1992-12-04 שילובים רוקחיים של רניטידין ביסמות ציטרט ותרכובת אנטי דלקתית שאינה סטרואיד לטיפול במצבים דלקתיים או להשכחת כאבים

Country Status (26)

Country Link
US (1) US5466436A (he)
EP (1) EP0550083B1 (he)
JP (1) JPH05246853A (he)
KR (1) KR930009605A (he)
AP (1) AP324A (he)
AT (1) AT401468B (he)
AU (1) AU664574B2 (he)
BE (1) BE1007268A3 (he)
CA (1) CA2084568A1 (he)
CH (1) CH685537A5 (he)
CZ (1) CZ358092A3 (he)
DE (1) DE69228738D1 (he)
DK (1) DK0550083T3 (he)
ES (1) ES2130152T3 (he)
FR (1) FR2684554B1 (he)
GB (1) GB2262036B (he)
GR (1) GR3030426T3 (he)
IE (1) IE922866A1 (he)
IL (1) IL103978A (he)
IT (1) IT1256697B (he)
LU (1) LU88196A1 (he)
MX (1) MX9207008A (he)
MY (1) MY108146A (he)
NO (1) NO303670B1 (he)
NZ (1) NZ245365A (he)
PH (1) PH31380A (he)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117412A (en) * 1995-01-26 2000-09-12 Nycomed Imaging As Non-cluster type bismuth compounds
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
WO1998022117A1 (en) * 1996-11-22 1998-05-28 The Procter & Gamble Company Compositions for the treatment of gastrointestinal disorders containing bismuth, and nsaid and one or more antimicrobials
WO1998022118A1 (en) * 1996-11-22 1998-05-28 The Procter & Gamble Company Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0000774D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
EE05234B1 (et) * 2001-03-08 2009-12-15 Astrazeneca Ab 6-karboksamidoimidaso[1,2-a] pridiinihendite kasutamine ravimi p?hjustatud maohaavandi v„ltimiseks
MXPA03011017A (es) 2001-06-01 2005-04-29 Pozen Inc Composiciones farmaceuticas para la entrega coordinada de nsaids.
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
US20080020040A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Unit dose form for administration of ibuprofen
US8067451B2 (en) * 2006-07-18 2011-11-29 Horizon Pharma Usa, Inc. Methods and medicaments for administration of ibuprofen
US20080021078A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Methods and medicaments for administration of ibuprofen
JP2009501801A (ja) * 2005-07-18 2009-01-22 ホライゾン セラピューティクス, インコーポレイテッド イブプロフェンとファモチジンとを含有する医薬およびその投与
US8067033B2 (en) 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
WO2008027963A2 (en) * 2006-08-31 2008-03-06 Horizon Therapeutics, Inc. Nsaid dose unit formulations with h2-receptor antagonists and methods of use
EP2344139A1 (en) 2008-09-09 2011-07-20 AstraZeneca AB Method for delivering a pharmaceutical composition to patient in need thereof
EA201290026A1 (ru) 2009-06-25 2012-07-30 Астразенека Аб Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid)
BR112014016085A8 (pt) 2011-12-28 2017-07-04 Pozen Inc composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico
CN110893233A (zh) * 2019-12-19 2020-03-20 川北医学院附属医院 一种鸢尾素在制备抗炎药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464679A (en) * 1981-07-06 1984-08-07 Rca Corporation Method and apparatus for operating a microprocessor in synchronism with a video signal
GB2105193B (en) * 1981-09-04 1984-09-12 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
SE8302689L (sv) * 1982-05-14 1983-11-15 Richter Gedeon Vegyeszet Farmaceutiska kompositioner innehallande flera aktiva bestandsdelar
US4757060A (en) * 1986-03-04 1988-07-12 Bristol-Myers Company Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
EP0282132B1 (en) * 1987-03-09 1992-09-30 The Procter & Gamble Company Compositions and their use for treating gastrointestinal disorders
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
CH679582A5 (he) * 1988-07-18 1992-03-13 Glaxo Group Ltd
NZ235877A (en) * 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions

Also Published As

Publication number Publication date
CA2084568A1 (en) 1993-06-07
NO924704D0 (no) 1992-12-04
AP9200453A0 (en) 1993-01-31
ITRM920869A0 (it) 1992-12-04
DE69228738D1 (de) 1999-04-29
GR3030426T3 (en) 1999-09-30
IE922866A1 (en) 1993-06-16
AU2986392A (en) 1993-06-10
CH685537A5 (fr) 1995-08-15
AP324A (en) 1994-03-07
NO303670B1 (no) 1998-08-17
MY108146A (en) 1996-08-30
MX9207008A (es) 1993-06-01
DK0550083T3 (da) 1999-10-11
FR2684554A1 (fr) 1993-06-11
GB2262036B (en) 1996-01-03
EP0550083B1 (en) 1999-03-24
NZ245365A (en) 1997-06-24
BE1007268A3 (fr) 1995-05-09
IL103978A0 (en) 1993-05-13
KR930009605A (ko) 1993-06-21
ITRM920869A1 (it) 1994-06-04
GB2262036A (en) 1993-06-09
EP0550083A1 (en) 1993-07-07
IT1256697B (it) 1995-12-12
FR2684554B1 (fr) 1995-09-08
US5466436A (en) 1995-11-14
ES2130152T3 (es) 1999-07-01
AU664574B2 (en) 1995-11-23
ATA240692A (de) 1996-02-15
AT401468B (de) 1996-09-25
NO924704L (no) 1993-06-07
CZ358092A3 (en) 1993-10-13
LU88196A1 (fr) 1993-08-17
PH31380A (en) 1998-10-29
GB9225174D0 (en) 1993-01-20
JPH05246853A (ja) 1993-09-24

Similar Documents

Publication Publication Date Title
US5466436A (en) Medicaments for treating inflammatory conditions or for analgesia
US4757060A (en) Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers
US5037815A (en) Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 - and H2 -receptor blockers
EP0533281B1 (en) The use of ranitidine bismuth citrate and in combination with claritromycin or claritromycin and tetracyclin in the manufacture of a medicament for treating gastrointestinal disorders
JPH06502854A (ja) 老年痴呆、過食症、片頭痛または食欲不振の治療用のパロキセチンの使用
FI117373B (fi) Parasetamolia ja domperidonia sisältävä kalvopäällysteinen tabletti
US4766117A (en) Antiinflammatory compositions and methods
RU2108097C1 (ru) Фармацевтическая композиция, содержащая соль ранитидина и карбоксилата висмута, и способ ее получения
JPH0428245B2 (he)
CA1330306C (en) Medicament for the treatment and prevention of nausea and vomiting
CZ270999A3 (cs) Farmaceutické prostředky obsahující ibuprofen a domperidone pro ošetřování migrény
JP2016014064A (ja) 医薬組成物
EP0017169B1 (en) Improved anti-inflammatory combinations having reduced ulcerogenicity
JPH0296525A (ja) 医薬
GB2216413A (en) Medicaments containing sufotidine
RU2134579C1 (ru) Лекарственные средства для лечения воспалительных состояний или для анальгезии
US4874757A (en) Antinflammatory compositions and methods
US4812455A (en) Antiinflammatory compositions and methods
US4672061A (en) Antiinflammatory compositions and methods
JP2900056B2 (ja) 非ステロイド抗炎症剤により生じる胃疾患の予防用医薬組成物
Maneksha 'Safapryn'and benorylate—a comparative trial of two new preparations of aspirin and paracetamol in the treatment of rheumatoid arthritis and osteoarthritis
JPH0143725B2 (he)
JPH07501076A (ja) 次サリチル酸ビスマスの単位剤形
BRPI1103205A2 (pt) Composição farmacêutica oral e uso da composição farmacêutica oral
JPS63250322A (ja) 消化器系疾患治療剤

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH1 Patent not in force